Here’s what you should know.
1. Olympus will pay $34 million to its foreign investors and they will dismiss remaining claims against the company.
2. In 2012, Olympus allegedly made several irregular payments for its acquisitions that resulted in a significant asset impairment charges. False financial statements concealed approximately ¥376 billion yen , according to the New York Times.
3. The company will record the payment as a special loss for its third quarter. It expects no change to the full year group forecast.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Henry Levine of the Center for Digestive Health
Welsh researchers make ‘breakthrough’ in diagnosing bowel cancer: 5 key notes
GI leader to know: Dr. Ivan Friedrich of The Gastroenterology Group of Northern New Jersey
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
